Janus Henderson Group PLC Ardelyx, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 15,057,940 shares of ARDX stock, worth $84.3 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,057,940
Previous 24,977,006
39.71%
Holding current value
$84.3 Million
Previous $123 Million
51.87%
% of portfolio
0.03%
Previous 0.07%
Shares
16 transactions
Others Institutions Holding ARDX
# of Institutions
225Shares Held
167MCall Options Held
551KPut Options Held
1.67M-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny11.7MShares$65.3 Million0.02% of portfolio
-
Macquarie Group LTD Australia, C311.5MShares$64.2 Million0.06% of portfolio
-
Marshall Wace, LLP London, X011.3MShares$63 Million0.05% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...